Vallerie Mclaughlin
Elite in Systemic Sclerosis (SSc)

Dr. Vallerie Mclaughlin

Cardiology
University Of Michigan Medical Center
1500 E Medical Center Dr, 
Ann Arbor, MI 
Offers Telehealth

Elite in Systemic Sclerosis (SSc)
University Of Michigan Medical Center
1500 E Medical Center Dr, 
Ann Arbor, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Vallerie Mclaughlin is a Cardiologist in Ann Arbor, Michigan. Dr. Mclaughlin is rated as an Elite provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Pulmonary Hypertension, Hypertension, Systemic Sclerosis (SSc), Angioplasty, and Heart Transplant.

Her clinical research consists of co-authoring 177 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 18 articles and participated in 2 clinical trials in the study of Systemic Sclerosis (SSc).

Specialties
Cardiology
Licenses
Internal Medicine in MI
Hospital Affiliations
University Of Michigan Health System
Edward W Sparrow Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Michigan Health
  • HMO
  • INSURANCE PLAN
  • MEDICARE MAPD
Upper Peninsula Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

University of Michigan Medical Center
1500 E Medical Center Dr, Ann Arbor, MI 48109
Call: 888-287-1082
Other Locations
Regents of the University of Michigan
3621 S State St, Ann Arbor, MI 48108
Call: 734-936-4000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sotatercept When Added to Maximum Tolerated Background Therapy in Participants With Pulmonary Arterial Hypertension (PAH) World Health Organization (WHO) Functional Class (FC) III or FC IV at High Risk Mortality
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sotatercept When Added to Maximum Tolerated Background Therapy in Participants With Pulmonary Arterial Hypertension (PAH) World Health Organization (WHO) Functional Class (FC) III or FC IV at High Risk Mortality
Enrollment Status: Completed
Publish Date: August 22, 2025
Intervention Type: Other, Drug
Study Drug: Sotatercept
Study Phase: Phase 3
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
Pilot Randomized Trial of Ambulatory Exercise in Pulmonary Hypertension
Pilot Randomized Trial of Ambulatory Exercise in Pulmonary Hypertension
Enrollment Status: Withdrawn
Publish Date: August 14, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
Clinical Evaluation of the Therapeutic Intra-Vascular Ultrasound (TIVUS™) System for Pulmonary Artery Denervation (PDN) in Patients With Pulmonary Hypertension - US
Clinical Evaluation of the Therapeutic Intra-Vascular Ultrasound (TIVUS™) System for Pulmonary Artery Denervation (PDN) in Patients With Pulmonary Hypertension - US
Enrollment Status: Unknown
Publish Date: August 21, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study to Compare the Efficacy and Safety of Sotatercept (ACE-011) Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study to Compare the Efficacy and Safety of Sotatercept (ACE-011) Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Completed
Publish Date: April 19, 2023
Intervention Type: Drug, Other
Study Drug: Sotatercept
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Other, Biological, Drug, Diagnostic test
Study Phase: Phase 2
A Double-blinded, Placebo-controlled Pilot Study of Dimethyl Fumarate (DMF) in Pulmonary Arterial Hypertension (PAH) Associated With Systemic Sclerosis (SSc-PAH): The Effect of DMF on Clinical Disease and Biomarkers of Oxidative Stress.
A Double-blinded, Placebo-controlled Pilot Study of Dimethyl Fumarate (DMF) in Pulmonary Arterial Hypertension (PAH) Associated With Systemic Sclerosis (SSc-PAH): The Effect of DMF on Clinical Disease and Biomarkers of Oxidative Stress.
Enrollment Status: Terminated
Publish Date: March 17, 2022
Intervention Type: Drug
Study Phase: Phase 1
View 7 Less Clinical Trials

177 Total Publications

Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
Journal: The New England journal of medicine
Published: September 30, 2025
View All 177 Publications
Similar Doctors
Distinguished in Systemic Sclerosis (SSc)
Dr. Nicole Bhave
Cardiology
Distinguished in Systemic Sclerosis (SSc)
Dr. Nicole Bhave
Cardiology

Preventative Cardiology At Dominos Farms

24 Frank Lloyd Wright Dr, 
Ann Arbor,, MI 
 (3.3 miles away)
734-998-7400
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nicole Bhave is a Cardiologist in Ann Arbor,, Michigan. Dr. Bhave is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Cardiomyopathy, Aortic Valve Stenosis, Thoracic Aortic Aneurysm, Cardiac Ablation, and Angioplasty.

Advanced in Systemic Sclerosis (SSc)
Dr. Sara Saberi
Cardiology
Advanced in Systemic Sclerosis (SSc)
Dr. Sara Saberi
Cardiology

Office

1425 E Ann St Spc 5856, 
Ann Arbor, MI 
 (1.1 miles away)
888-287-1082
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sara Saberi is a Cardiologist in Ann Arbor, Michigan. Dr. Saberi is rated as an Elite provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Cardiac Ablation, and Pacemaker Implantation.

Advanced in Systemic Sclerosis (SSc)
Dr. Victor Moles
Cardiology
Advanced in Systemic Sclerosis (SSc)
Dr. Victor Moles
Cardiology

University Of Michigan Medical Center

1500 E Medical Center Dr, 
Ann Arbor,, MI 
 (0.2 miles away)
888-287-1082
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Victor Moles is a Cardiologist in Ann Arbor,, Michigan. Dr. Moles is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Pulmonary Embolism, Pulmonary Edema, and Angioplasty.

VIEW MORE SYSTEMIC SCLEROSIS (SSC) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mclaughlin's expertise for a condition
ConditionClose
  • Elite
  • Hypertension
    Dr. Mclaughlin is
    Elite
    . Learn about Hypertension.
    See more Hypertension experts
  • Pulmonary Hypertension
    Dr. Mclaughlin is
    Elite
    . Learn about Pulmonary Hypertension.
    See more Pulmonary Hypertension experts
  • Systemic Sclerosis (SSc)
    Dr. Mclaughlin is
    Elite
    . Learn about Systemic Sclerosis (SSc).
    See more Systemic Sclerosis (SSc) experts
  • Distinguished
  • Congenital Heart Disease (CHD)
    Dr. Mclaughlin is
    Distinguished
    . Learn about Congenital Heart Disease (CHD).
    See more Congenital Heart Disease (CHD) experts
  • Pulmonary Embolism
    Dr. Mclaughlin is
    Distinguished
    . Learn about Pulmonary Embolism.
    See more Pulmonary Embolism experts
  • Pulmonary Veno-Occlusive Disease
    Dr. Mclaughlin is
    Distinguished
    . Learn about Pulmonary Veno-Occlusive Disease.
    See more Pulmonary Veno-Occlusive Disease experts
  • Advanced
  • Angioplasty
    Dr. Mclaughlin is
    Advanced
    . Learn about Angioplasty.
    See more Angioplasty experts
  • Eisenmenger Syndrome
    Dr. Mclaughlin is
    Advanced
    . Learn about Eisenmenger Syndrome.
    See more Eisenmenger Syndrome experts
  • Heart Failure
    Dr. Mclaughlin is
    Advanced
    . Learn about Heart Failure.
    See more Heart Failure experts
  • Heart Failure with Preserved Ejection Fraction (HFpEF)
    Dr. Mclaughlin is
    Advanced
    . Learn about Heart Failure with Preserved Ejection Fraction (HFpEF).
    See more Heart Failure with Preserved Ejection Fraction (HFpEF) experts
  • Pulmonary Edema
    Dr. Mclaughlin is
    Advanced
    . Learn about Pulmonary Edema.
    See more Pulmonary Edema experts
  • Undifferentiated Connective Tissue Disease (UCTD)
    Dr. Mclaughlin is
    Advanced
    . Learn about Undifferentiated Connective Tissue Disease (UCTD).
    See more Undifferentiated Connective Tissue Disease (UCTD) experts
  • Experienced
  • Angina
    Dr. Mclaughlin is
    Experienced
    . Learn about Angina.
    See more Angina experts
  • Aortic Regurgitation
    Dr. Mclaughlin is
    Experienced
    . Learn about Aortic Regurgitation.
    See more Aortic Regurgitation experts
  • Aortic Valve Stenosis
    Dr. Mclaughlin is
    Experienced
    . Learn about Aortic Valve Stenosis.
    See more Aortic Valve Stenosis experts
  • Apoplexy
    Dr. Mclaughlin is
    Experienced
    . Learn about Apoplexy.
    See more Apoplexy experts
  • Arrhythmias
    Dr. Mclaughlin is
    Experienced
    . Learn about Arrhythmias.
    See more Arrhythmias experts
  • Arrhythmogenic Right Ventricular Cardiomyopathy
    Dr. Mclaughlin is
    Experienced
    . Learn about Arrhythmogenic Right Ventricular Cardiomyopathy.
    See more Arrhythmogenic Right Ventricular Cardiomyopathy experts
View All 49 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.